US2017304319A1PendingUtilityA1
Dexamethasone oral film
Est. expiryNov 4, 2034(~8.3 yrs left)· nominal 20-yr term from priority
Inventors:Bengt Westrin
A61P 7/10A61P 37/08A61P 37/06A61P 25/18A61P 29/00A61P 1/08A61P 25/00A61K 9/0056A61K 31/573A61K 47/38A61K 9/7007A61K 9/006
18
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to an oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w based on total dry matter.
Claims
exact text as granted — not AI-modified1 .- 18 . (canceled)
19 . An oral film consisting essentially of dexamethasone and hydroxypropyl methylcellulose, wherein the concentration of dexamethasone is 30% w/w or more and the concentration of hydroxypropyl methylcellulose is between 35 and 70% w/w, all based on total dry matter.
20 . An oral film according to claim 19 , wherein the sum of the concentrations of dexamethasone and hydroxypropyl methylcellulose is from 95% to 100% w/w.
21 . An oral film according to claim 19 , wherein the hydroxypropyl methylcellulose is hypromellosum, Ph. Eur.
22 . An oral film according to claim 19 , wherein the hydroxypropyl methylcellulose is hypromellose, USP.
23 . An oral film according to claim 19 , wherein the hydroxypropyl methylcellulose is type 2910.
24 . An oral film according to claim 19 , wherein the hydroxypropyl methylcellulose is a mixture of two or more hydroxypropyl methylcelluloses having different viscosity.
25 . An oral film according to claim 24 , wherein the hydroxypropyl methylcellulose is a mixture of two hydroxypropyl methylcelluloses having different viscosity, wherein the concentrations of the two hydroxypropyl methylcelluloses in the film are the same.
26 . An oral film according to claim 19 , wherein the hydroxypropyl methylcellulose is a mixture of hydroxypropyl methylcelluloses having a viscosity of 3 mPa s and 50 mPa s, respectively.
27 . An oral film according to claim 19 , wherein the concentration of dexamethasone is from 35 to 45% w/w.
28 . An oral film according to claim 27 , wherein the concentration of dexamethasone is 40% w/w.
29 . An oral film according to claim 19 , wherein the total concentration of hydroxypropyl methylcellulose is from 55 to 65% w/w.
30 . An oral film according to claim 19 , containing a mixture of two hydroxypropyl methylcelluloses having a viscosity of 3 mPa s and 50 mPa s, respectively, wherein the total concentration of the mixture is 60% w/w.
31 . An oral film according to claim 19 , wherein dexamethasone is present in micronized form.
32 . An oral film according claim 19 , wherein the film has a thickness of from 15 to 50 μm.
33 . An oral film according to claim 19 in unit dosage form.
34 . An oral film according to claim 33 , wherein the unit dosage form contains from 4 to 10 mg of dexamethasone.
35 . A method of treating a condition selected from chemotherapy induced nausea, chemotherapy induced vomiting, croup, acute allergic conditions, anaphylactic conditions, brain oedema, and high-altitude disease, comprising orally administering an oral film according to claim 19 to a subject in need thereof.
36 . A method for preparing an oral film according to claim 19 , comprising:
i) dispersing dexamethasone in water to obtain a dispersion, ii) dissolving hydroxypropyl methylcellulose in said dispersion, iii) coating the dispersion resulting from step ii) on an intermediate layer to obtain a wet film, iv) drying the wet film, and v) removing the intermediate layer.
37 . A method for preparing an oral film according to claim 19 , comprising:
i) dissolving hydroxypropyl methylcellulose in water to obtain a homogeneous viscous solution, ii) dispersing dexamethasone in said solution, and obtaining a homogeneous viscous dispersion containing all ingredients, iii) coating the dispersion resulting from step ii) on an intermediate layer to obtain a wet film, iv) drying the wet film, and v) removing the intermediate layer.Join the waitlist — get patent alerts
Track US2017304319A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.